Thursday, October 16, 2025

Light/Dark

Breaking News

BNP Paribas & Proxymity Transform Shareholder Meetings With Real-Time Connectivity SGX FX and BBVA Announce Partnership to Expand Liquidity in The Americas AmFi and Helix Forge Strategic Partnership to Open Latin America’s Private Credit Market to Asian Investors EXCLUSIVE: “Sharing is Caring” – Jamie Renehan, Bank of Ireland in ‘The Fintech Magazine’ Chainlink Enables Banks to Transact On-Chain Securely and Seamlessly Backbase on AI Execution & Banking Transformation Primer Sets a New Standard for All Checkouts, Combining Simplicity and a Brand-Perfect Experience Klarna Launches Flexible Debit Card and Digital Wallet in UK Zurich Strengthens Its Fraud Defences With Real-time AI, Connecting Industry-Wide Claims Data ACI Worldwide and BitPay Partner to Power Crypto and Stablecoin Payments for Global Merchants and Payment Service Providers Mastercard Survey: 91% of Jamaican SMEs Using Digital Payments Says It Has Led to Business Growth U.S. Bank Establishes New Digital Assets and Money Movement Organization Cross-Border Payments Startup Grey Targets $64B North Africa Market with Morocco and Egypt Launch Yaspa Unveils New Brand Identity as Payments and Identity Fintech Accelerates Global Growth Juspay Partners With HSBC to Build a Full-Stack, Future-Ready Acquiring Solution

Home » People » Tan Truong

Lamin Jaiteh

Connect

About Tan Truong

https://in-prepaid.com/

News

News

Dash Solutions expands its payments platform into healthcare and clinical trials, with COO Tan Truong and CEO Stephen Faust highlighting 20% growth in 2025.

Dash Solutions Expands Reach of Unified Payments Platform in Regulated Industries

September 11 2025

Dash Solutions, the leader in payments enablement, today announced the expanded reach of its unified, enterprise-grade platform, which currently powers complex payment workflows for banking, government and other regulated industries. Building on this foundation, Dash Solutions is rapidly scaling in healthcare and clinical research, with the company on pace to grow its clinical trials business by 20% this year alone.

Related Companies